Giles Richard Platford

Insider profile

Giles Richard Platford's trades of Takeda Pharmaceutical Co Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
179.71
Quantity 50,247
Value US$3,236,803
Transaction date
Proposed sale
Price
248.85
Quantity 17,703
Value US$2,113,330
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-12 2026-08-10 S Sale
50,732 +24.1%
349.39
US$992,647
50,732 +24.1% 349.39 US$992,647
2026-07-13 2026-07-13 PrS Proposed sale
50,247
179.71
US$3,236,803
50,247 179.71 US$3,236,803
2025-12-04 2025-12-04 PrS Proposed sale
17,703
248.85
US$2,113,330
17,703 248.85 US$2,113,330
2025-07-09 2025-07-09 PrS Proposed sale
28,552
15.42
US$440,272
28,552 15.42 US$440,272
2024-08-22 2024-08-23 PrS Proposed sale
19,073
14.94
US$284,951
19,073 14.94 US$284,951
2024-07-10 2024-07-11 PrS Proposed sale
20,721
13.18
US$273,103
20,721 13.18 US$273,103
2023-07-10 2023-07-11 PrS Proposed sale
24,394
15.48
US$377,620
24,394 15.48 US$377,620